title: Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data.
authors.affiliation: Department of Haematology, Catalan Institute of Oncology, Barcelona, Spain. rduarte@iconcologia.net
authors.forename: R F
authors.initials: RF
authors.lastname: Duarte
authors.forename: B E
authors.initials: BE
authors.lastname: Shaw
authors.forename: P
authors.initials: P
authors.lastname: Marín
authors.forename: P
authors.initials: P
authors.lastname: Kottaridis
authors.forename: M
authors.initials: M
authors.lastname: Ortiz
authors.forename: C
authors.initials: C
authors.lastname: Morante
authors.forename: J
authors.initials: J
authors.lastname: Delgado
authors.forename: J
authors.initials: J
authors.lastname: Gayoso
authors.forename: R
authors.initials: R
authors.lastname: Goterriz
authors.forename: C
authors.initials: C
authors.lastname: Martínez-Chamorro
authors.forename: J J
authors.initials: JJ
authors.lastname: Mateos-Mazón
authors.forename: C
authors.initials: C
authors.lastname: Ramírez
authors.forename: J
authors.initials: J
authors.lastname: de la Rubia
authors.forename: H
authors.initials: H
authors.lastname: Achtereekte
authors.forename: P J
authors.initials: PJ
authors.lastname: Gandhi
authors.forename: K W
authors.initials: KW
authors.lastname: Douglas
authors.forename: N H
authors.initials: NH
authors.lastname: Russell
mesh_terms: D000328:Adult; D000368:Aged; D018952:Antigens, CD34 / Q000097:blood; D001596:Benzylamines; D015331:Cohort Studies; D057176:Compassionate Use Trials; D000080027:Cyclams; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005062:European Union; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D019650:Hematopoietic Stem Cell Mobilization / Q000009:adverse effects / Q000379:methods*; D006571:Heterocyclic Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D018952:Antigens, CD34; D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D016179:Granulocyte Colony-Stimulating Factor; C088327:plerixafor